DDIT3 and B-cell non-Hodgkin lymphoma: Doxorubicin and 5-fluorouracil had been used together in the F-MACHOP regimen until the late 90s, and doxorubicin continues to be used today in standard therapies for B-cell lymphoma (either CHOP or R-CHOP) [9], [69].